Precision Medicine in Breast Cancer: From Epidemiology to Cancer Prevention, Screening and Early Detection
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 4592
Special Issue Editor
Interests: cancer epidemiology; cancer disparities; cancer prevention; screening and early detection; genetic testing; breast cancer; cancer genomics; precision medicine
Special Issue Information
Dear Colleagues,
A large body of literature heralds the potential benefits of precision medicine—a paradigm that uses individual variation in genes, environment, and lifestyle to improve disease prevention, diagnosis, and treatment. Breast cancer has been at the forefront of precision medicine. However, precision medicine approaches to breast cancer prevention have lagged behind advances in treatment. Expanding our ability to tailor and implement effective preventive interventions is necessary to fully realize the promise of precision medicine for public health. We are pleased to invite you to submit a manuscript for this Special Issue on breast cancer precision medicine as it relates to cancer prevention, screening, and early detection. This Special Issue aims to showcase epidemiological, clinical, and translational research that moves the field toward the precision prevention of breast cancer. Research areas may include (but are not limited to) the following: improved risk assessment tools, novel biomarkers of risk, chemoprevention, genetic susceptibility, impact of precision medicine on health disparities, relevant data integration and analytic methods, and the implementation of precision prevention strategies. In this Special Issue, original research articles and reviews are welcome. We look forward to receiving your contributions.
Dr. Anne Marie McCarthy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- precision medicine
- precision prevention
- personalized screening
- screening
- early detection
- risk assessment
- biomarkers
- genetic susceptibility